NCT02615054
- Conditions
- HER2-Positive Breast Cancer Survivors, Trastuzumab Cardiotoxicity
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
HER2-Positive Breast Cancer Survivors
Explore clinical trials studying HER2-Positive Breast Cancer Survivors. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies